COM:UROGEN
UroGen Pharma
- Stock
Last Close
11.55
22/11 21:00
Market Cap
502.60M
Beta: -
Volume Today
390.58K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 17.53M - | 8.16M 53.46% | 1.13M 86.17% | 18K 98.40% | 11.80M 65,450% | 48.04M 307.17% | 64.36M 33.96% | 82.71M 28.52% | ||
cost of revenue | 28K - | 600K 2,042.86% | 1.80M 200.50% | 1.01M - | 5.16M 411.10% | 7.65M 48.42% | 9.36M 22.30% | |||
gross profit | 17.50M - | 7.56M 56.82% | -675K 108.93% | 18K 102.67% | 10.79M 59,844.44% | 42.88M 297.45% | 56.70M 32.22% | 73.35M 29.36% | ||
selling and marketing expenses | ||||||||||
general and administrative expenses | 1.90M - | 6.42M 238.63% | 8.81M 37.31% | 39.57M 349.11% | 60.20M 52.13% | |||||
selling general and administrative expenses | 1.90M - | 6.42M 238.63% | 8.81M 37.31% | 39.57M 349.11% | 60.20M 52.13% | 90.22M 49.87% | 87.53M 2.97% | 82.84M 5.37% | 93.27M 12.60% | |
research and development expenses | 10.52M - | 10.29M 2.17% | 18.70M 81.75% | 36.93M 97.54% | 49.30M 33.47% | 47.31M 4.03% | 47.64M 0.70% | 52.91M 11.05% | 45.61M 13.78% | |
other expenses | -284K - | 838K - | ||||||||
cost and expenses | 12.41M - | 16.73M 34.83% | 28.11M 67.99% | 78.31M 178.60% | 109.50M 39.83% | 138.54M 26.52% | 140.33M 1.30% | 143.40M 2.18% | 148.25M 3.38% | |
operating expenses | 12.41M - | 16.70M 34.60% | 27.51M 64.68% | 76.50M 178.12% | 109.50M 43.12% | 137.53M 25.60% | 135.18M 1.71% | 135.74M 0.42% | 138.89M 2.32% | |
interest expense | -4.33M - | 8.44M - | 36.27M 329.81% | |||||||
ebitda | -12.30M - | 1.01M 108.22% | -19.95M 2,073.29% | -77.18M 286.87% | -108.15M 40.13% | -126.74M 17.18% | -75.00M 40.82% | -78.03M 4.04% | -63.83M 18.20% | |
operating income | -12.41M - | 798K 106.43% | -19.95M 2,600% | -77.18M 286.87% | -109.48M 41.85% | -126.74M 15.77% | -92.29M 27.18% | -79.04M 14.36% | -65.54M 17.09% | |
depreciation and amortization | 113K - | 213K 88.50% | 207K 2.82% | 417K 101.45% | 1.32M 217.51% | 2.04M 54.38% | 17.29M 745.94% | 1.01M 94.16% | 1.71M 68.81% | |
total other income expenses net | -279K - | -2.74M 881.72% | -31K 98.87% | -100K 222.58% | 4.33M 4,432% | 1.63M 62.40% | -17.08M 1,148.43% | -28.99M 69.72% | -32.79M 13.11% | |
income before tax | -12.69M - | -1.94M 84.70% | -19.98M 929.42% | -75.53M 278.02% | -105.15M 39.21% | -125.11M 18.99% | -109.37M 12.58% | -108.03M 1.23% | -98.32M 8.98% | |
income tax expense | 19K - | 125K 557.89% | -4.62M 3,792.80% | 3.37M 173.09% | 1.45M 57.05% | 1.14M 21.67% | 3.92M 245.37% | |||
net income | -12.69M - | -1.94M 84.70% | -20M 930.40% | -75.66M 278.28% | -100.53M 32.88% | -128.48M 27.81% | -110.82M 13.75% | -109.16M 1.50% | -102.24M 6.34% | |
weighted average shs out | 11.97M - | 11.97M 0% | 9.72M 18.84% | 15.75M 62.13% | 20.53M 30.31% | 21.78M 6.10% | 22.35M 2.60% | 22.81M 2.06% | 28.83M 26.43% | |
weighted average shs out dil | 11.97M - | 11.97M 0% | 9.72M 18.84% | 15.75M 62.13% | 20.53M 30.31% | 21.78M 6.10% | 22.35M 2.60% | 22.81M 2.06% | 28.83M 26.43% | |
eps | -1.06 - | -0.16 84.91% | -2.06 1,187.50% | -4.80 133.01% | -4.90 2.08% | -5.90 20.41% | -4.96 15.93% | -4.79 3.43% | -3.55 25.89% | |
epsdiluted | -1.06 - | -0.16 84.91% | -2.06 1,187.50% | -4.80 133.01% | -4.90 2.08% | -5.90 20.41% | -4.96 15.93% | -4.79 3.43% | -3.55 25.89% |
All numbers in (except ratios and percentages)